Exposure to Antimuscarinic Medications for Treatment of Overactive Bladder and Risk of Lung Cancer and Colon Cancer

Clinical Epidemiology - New Zealand
doi 10.2147/clep.s186842
Full Text
Abstract

Available in full text

Categories
Epidemiology
Date
Authors
Publisher

Informa UK Limited

Related search

Bladder Cancer and Occupational Exposure to Leather.

Occupational and Environmental Medicine
EnvironmentalPublic HealthOccupational Health
1986English

Correction To: Imidafenacin for the Treatment of Overactive Bladder

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2013English

Variation in Cardiovascular Risk Related to Individual Antimuscarinic Drugs Used to Treat Overactive Bladder. A Cohort Study in the UK

Pharmacotherapy
Pharmacology
2018English

Residential Radon Exposure and Risk of Lung Cancer in Missouri.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1999English

OnabotulinumtoxinA for the Treatment of Overactive Bladder

Research and Reports in Urology
Urology
2014English

Selenium and Risk of Bladder Cancer

Hereditary Cancer in Clinical Practice
OncologyGenetics
2012English

Attributable Risk of Lung Cancer Deaths Due to Indoor Radon Exposure

Annals of Occupational and Environmental Medicine
EnvironmentalPublic HealthOccupational Health
2016English

Exposure to Oral Bisphosphonates and Risk of Cancer

International Journal of Cancer
Cancer ResearchOncology
2012English

Low-Level Exposure to Arsenic in Drinking Water and Risk of Lung and Bladder Cancer: A Systematic Review and Dose–Response Meta-Analysis

Dose-Response
Chemical HealthMutagenesisPublic HealthEnvironmentalSafetyToxicologyHealthOccupational Health
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy